Skip to content

Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury

Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04165369
Acronym
Epis-AKI
Enrollment
10568
Registered
2019-11-18
Start date
2020-06-09
Completion date
2022-03-31
Last updated
2022-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury (AKI)

Keywords

Acute kidney injury, injury, surgery

Brief summary

The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit.

Detailed description

Acute kidney injury (AKI) is a severe clinical complication with increasing incidence and is associated with adverse short- and long-term outcomes resulting in a major health care burden worldwide. The introduction of consensus classification systems has enhanced the awareness for AKI. The evaluation of an accurate occurrence rate for AKI is of great importance for health policy, quality initiatives as well as for designing clinical trials. However, analyzing AKI from existing databases is often limited by missing data elements, especially the inclusion of the urine output criteria. Missing data and the use of different definitions before the consensus classification are the reasons for large variations in reported occurrences of surgical induced AKI. The primary objective is to prospectively evaluate the incidence of AKI within 72 h after extended surgical procedures that require admission to an observation unit (e.g., Intensive Care Unit, Intermediate Care, Post Anesthesia Care Unit) using the latest consensus definition for AKI (Kidney Disease: Improving Global Outcomes criteria) and a standardized data collection instrument and to assess the dependence of AKI on preoperative and intraoperative factors. Method: International prospective, observational, multi-center, cross-sectional cohort study Eligible patients will be identified during preoperative assessment. All eligible patients will be approached to obtain written consent.

Interventions

None listed

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
University Hospital Muenster
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* major elective or emergency surgery procedures with a duration of at least 2 h * admission to the intensive care unit, intermediate care unit after surgery informed consent

Exclusion criteria

* preexisting acute kidney injury * acute kidney injury within the last 3 months * end stage renal disease with dialysis dependency * kidney transplant

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Acute Kidney Injury72 hours after extended surgeryOccurrence of acute kidney injury according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria

Secondary

MeasureTime frameDescription
Number of patients with renal replacement therapyup to 90 days after extended surgery
Mortalityup to 90 days after extended surgery
Severity of acute kidney injury (number of patients with KDIGO stage 1, KDIGO stage 2 or KDIGO stage 3)72 hours after extended surgeryDefinition and classification of acute injury according to the KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guidelines on acute kidney injury
Intensive Care Unit stayup to 90 days after extended surgery (until discharge)
Major Adverse Kidney Events (MAKE)up to 90 days after extended surgerycombined endpoint consisting of mortality, renal replacement therapy, persistent renal dysfunction defined as serum-creatinine \>= 1.5 times as compared to baseline serum-creatinine
Hospital stayup to 90 days after extended surgery (until discharge)

Countries

Egypt, France, Germany, Italy, Libya, Malta, North Macedonia, Palestinian Territories, Russia, Saudi Arabia, Slovenia, Spain, Turkey (Türkiye), United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026